Trial intelligence / Profile preview

Feasibility of Patient Controlled Sedation for Ventilated ICU Patients

NCT01606852Phase 2Completed

Sponsor
University of Minnesota
Start
Mar 2013
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine in anxiety disorder, sponsored by University of Minnesota. Started Mar 2013; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on NCT01606852.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01606852.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call